ABTB2

UniProt ID: Q8N961
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

ABTB2 is a large ankyrin-repeat and BTB/POZ-domain protein with protein-protein interaction domains and isoform diversity. Direct experimental work in pancreatic ductal adenocarcinoma models supports a substrate-adaptor-like role in which ABTB2 binds TRAP1, promotes TRAP1 ubiquitination-dependent degradation, and suppresses Wnt/beta-catenin and PI3K/Akt signaling. ABTB2 has been detected in the nucleoplasm, but its normal tissue substrates and broader physiological roles remain incompletely defined.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0046982 protein heterodimerization activity
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: This InterPro-derived annotation is consistent with ABTB2 containing protein-interaction domains, including histone-fold-like, ankyrin-repeat, and BTB/POZ features, but it is too broad to describe ABTB2's best-supported molecular function.
Reason: Retain the domain context but do not treat generic heterodimerization as a core function. The direct ABTB2 literature supports a more informative substrate-adaptor-like role in TRAP1 ubiquitination-dependent degradation, captured below as GO:1990756.
Supporting Evidence:
UniProt:Q8N961
DR InterPro; IPR009072; Histone-fold.
PMID:41322190
ABTB2 interacts with tumour necrosis factor receptor-associated protein 1 (TRAP1), promoting its ubiquitin-dependent degradation
GO:0005515 protein binding
IPI
PMID:36931259
A central chaperone-like role for 14-3-3 proteins in human c...
MARK AS OVER ANNOTATED
Summary: The IPI annotation records a 14-3-3 epsilon/YWHAE interaction detected in a broad 14-3-3 interactome study. This supports an ABTB2 protein interaction but not a specific molecular activity.
Reason: GO:0005515 is intentionally generic and is not useful as a retained core molecular-function annotation. ABTB2's direct, more informative function is better represented as ubiquitin-like ligase-substrate adaptor activity.
Supporting Evidence:
UniProt:Q8N961
CC Q8N961; P62258: YWHAE; NbExp=2; IntAct=EBI-11603395, EBI-356498;
PMID:36931259
Here, we map the interactomes of all human 14-3-3 paralogs
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: HPA immunofluorescence supports nucleoplasm localization. Direct ABTB2 functional work also links the protein to intracellular protein-complex contexts, but localization is not itself the core proteostasis function.
Reason: Keep as a supported localization/context annotation. It should not be used to infer a nuclear-specific core function, since the strongest mechanistic evidence concerns ABTB2-dependent TRAP1 ubiquitination and degradation in cancer models.
GO:1990756 ubiquitin-like ligase-substrate adaptor activity
IDA
PMID:41322190
Mechanistic and functional characterization of ABTB2 as a no...
NEW
Summary: Lyu et al. identify TRAP1 as an ABTB2-interacting protein and show that ABTB2 overexpression increases TRAP1 ubiquitination and promotes TRAP1 degradation. The same study reports ABTB2 interaction with cullin-3, making the PN-projected Cul3 substrate-receptor context supportable for ABTB2.
Reason: This is the most informative molecular-function term for the direct ABTB2 evidence. It captures ABTB2's substrate-adaptor-like role in bringing a ubiquitin-ligase system to a substrate, while avoiding a catalytic E3-ligase annotation. The older BPOZ-2/TdT and BPOZ-2/eEF1A1 literature was not used as primary ABTB2 evidence because that nomenclature overlaps with ABTB1; the 2025 ABTB2/TRAP1 study provides direct gene-specific support.
Supporting Evidence:
PMID:41322190
Co-immunoprecipitation using Abs specific to ABTB2 and TRAP1, followed by western blotting, confirmed the specific interaction between ABTB2 and TRAP1
PMID:41322190
multiple mono-ubiquitinated TRAP1 (Figures 8F and S10) in ABTB2-OE cells, suggesting that ABTB2-induced protein ubiquitination contributes to TRAP1 degradation
PMID:41322190
We also found that ABTB2 interacts with cullin-3 (Figure S9)
file:human/ABTB2/ABTB2-deep-research-manual.md
Direct ABTB2 evidence supports a substrate-adaptor-like role for TRAP1 ubiquitination-dependent degradation.
GO:0016567 protein ubiquitination
IDA
PMID:41322190
Mechanistic and functional characterization of ABTB2 as a no...
NEW
Summary: ABTB2 overexpression increases pan-protein ubiquitination and TRAP1 ubiquitination, with TRAP1 degradation downstream of the ABTB2-TRAP1 interaction.
Reason: Add as a biological-process companion to the molecular-function adaptor annotation. The evidence supports ABTB2 involvement in TRAP1 protein ubiquitination, while the molecular-function annotation should remain adaptor activity rather than catalytic ubiquitin ligase activity.
Supporting Evidence:
PMID:41322190
Using western blotting, we detected abundant ubiquitination of whole proteins (Figure 8E) and multiple mono-ubiquitinated TRAP1 (Figures 8F and S10) in ABTB2-OE cells
PMID:41322190
ABTB2 promotes TRAP1 degradation via ubiquitination (Figure 8)
file:human/ABTB2/ABTB2-deep-research-manual.md
Add `GO:0016567 protein ubiquitination` as a new biological-process companion annotation

Core Functions

ABTB2 acts as a BTB/POZ substrate-adaptor-like protein for ubiquitin-dependent degradation of TRAP1 in pancreatic cancer models, consistent with the Proteostasis PN Cul3 substrate-receptor projection.

Supporting Evidence:
  • PMID:41322190
    ABTB2 promotes TRAP1 degradation via ubiquitination (Figure 8). We also found that ABTB2 interacts with cullin-3 (Figure S9)

References

Gene Ontology annotation through association of InterPro records with GO terms
  • InterPro-based annotation projected a generic protein heterodimerization activity term to ABTB2 from domain associations.
    "The ABTB2 GOA record includes an IEA annotation to GO:0046982 protein heterodimerization activity with GO_REF:0000002 as the source reference."
Gene Ontology annotation based on curation of immunofluorescence data
  • Immunofluorescence-based curation supports nucleoplasm localization for ABTB2.
    "The ABTB2 GOA record includes an IDA annotation to GO:0005654 nucleoplasm with GO_REF:0000052 as the source reference."
A central chaperone-like role for 14-3-3 proteins in human cells.
  • ABTB2 was identified as an interactor of 14-3-3 epsilon (YWHAE) in a systematic mapping of human 14-3-3 paralog interactomes.
    "Here, we map the interactomes of all human 14-3-3 paralogs"
Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy.
  • ABTB2 interacts with TRAP1 and promotes TRAP1 ubiquitination-dependent degradation in pancreatic cancer models.
    "Transcriptomic analysis, immunoprecipitation, and functional assays demonstrated that ABTB2 interacts with tumour necrosis factor receptor-associated protein 1 (TRAP1), promoting its ubiquitin-dependent degradation"
  • The authors report that ABTB2 also interacts with cullin-3, supporting a substrate-adaptor-like model.
    "We also found that ABTB2 interacts with cullin-3 (Figure S9)"
UniProt:Q8N961
UniProt record for ABTB2 (Q8N961)
  • ABTB2 contains ankyrin-repeat and BTB/POZ-domain features.
    "FT /note="BTB""
file:projects/PROTEOSTASIS/reports/pn_projection/pn_projected_annotations.tsv
Proteostasis PN projected annotation report
  • The Proteostasis PN projection places ABTB2 in the Cul3 substrate-receptor branch and projects GO:1990756.
    "ABTB2 Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor|BTB-BACK, variant|ankyrin"
file:human/ABTB2/ABTB2-deep-research-manual.md
Manual deep research fallback for ABTB2 PN review
  • Manual fallback review supports accepting GO:1990756 for ABTB2 based on direct ABTB2-TRAP1 ubiquitination/degradation and reported ABTB2-cullin-3 interaction.
    "Direct ABTB2 evidence supports a substrate-adaptor-like role for TRAP1 ubiquitination-dependent degradation."

Suggested Questions for Experts

Q: Does endogenous ABTB2 form a native CRL3 complex with CUL3 in non-cancer tissues, and is TRAP1 a physiological substrate outside pancreatic cancer models?

Q: What additional ABTB2 substrates explain its tissue-specific and disease-context effects?

Suggested Experiments

Experiment: Test endogenous ABTB2-CUL3-TRAP1 complex formation with reciprocal co-IP, proximity ligation, and BTB-domain mutant rescue in cells with native ABTB2 expression.

Hypothesis: ABTB2 uses its BTB/POZ domain to recruit CUL3 while its substrate-recognition regions engage TRAP1.

Type: co-immunoprecipitation and mutant rescue

Experiment: Measure TRAP1 ubiquitination and stability after ABTB2 loss or rescue with CUL3 depletion, proteasome inhibition, and ubiquitin-linkage/site mapping.

Hypothesis: ABTB2-dependent TRAP1 degradation requires a CUL3 ubiquitin-ligase complex.

Type: ubiquitination and protein-turnover assay

Deep Research

Manual

(ABTB2-deep-research-manual.md)
ABTB2 manual deep research fallback Manual

ABTB2 manual deep research fallback

Falcon deep research was attempted with just deep-research-falcon human ABTB2 --fallback perplexity-lite. Falcon timed out after 600 seconds, and the configured fallback failed with a Perplexity API quota error. This manual fallback records the evidence used for the ABTB2 Proteostasis PN review.

Summary

ABTB2 (UniProt Q8N961) encodes a reviewed 1025-aa ankyrin-repeat and BTB/POZ-domain protein. UniProt lists ankyrin repeats, a BTB domain, ABTB2/3 histone-fold-like features, and sparse functional annotation, with the statement that ABTB2 may be involved in initiation of hepatocyte growth [UniProt:Q8N961 "May be involved in the initiation of hepatocyte growth"]. GOA initially contained only InterPro-derived protein heterodimerization activity, an IntAct/YWHAE protein binding row, and HPA nucleoplasm localization.

The Proteostasis PN projection places ABTB2 under the Cul3 substrate-receptor branch and projects GO:1990756 ubiquitin-like ligase-substrate adaptor activity [file:projects/PROTEOSTASIS/reports/pn_projection/pn_projected_annotations.tsv "ABTB2 Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor|BTB-BACK, variant|ankyrin"]. Because this branch contains domain-based cases, the projection was evaluated against gene-specific evidence.

The strongest direct ABTB2 evidence is the 2025 Molecular Therapy Oncology study in pancreatic ductal adenocarcinoma. The abstract reports that ABTB2 interacts with TRAP1 and promotes TRAP1 ubiquitin-dependent degradation PMID:41322190. In the results, anti-ABTB2 immunoprecipitation/mass spectrometry identified TRAP1, reciprocal co-IP confirmed ABTB2-TRAP1 interaction, and ABTB2 overexpression increased pan-protein ubiquitination and mono-ubiquitinated TRAP1 PMID:41322190 PMID:41322190. The discussion further states that ABTB2 interacts with cullin-3 and interprets ABTB2 as a substrate-specific adaptor for ubiquitin-dependent TRAP1 degradation PMID:41322190 PMID:41322190.

The 14-3-3 paper underlying the original protein binding row is useful only as interaction-context evidence. It mapped 14-3-3 interactomes and showed that loss of 14-3-3 binding can affect client localization/aggregation PMID:36931259. That does not define ABTB2's molecular activity.

Older BPOZ-2 papers report Cul3 and substrate-degradation biology, but they were treated as nomenclature caution rather than primary ABTB2 evidence. The cached TdT paper states that BPOZ-2 bound CUL3 and promoted TdT ubiquitination/degradation PMID:18429817. Current identifier usage overlaps BPOZ-2 with ABTB1, so these papers should not be projected to Q8N961 without identifier-level confirmation.

Curation conclusions

  • Add GO:1990756 ubiquitin-like ligase-substrate adaptor activity as a new direct ABTB2 molecular-function annotation, supported by ABTB2-TRAP1 co-IP, TRAP1 ubiquitination/degradation, and reported ABTB2-cullin-3 interaction.
  • Add GO:0016567 protein ubiquitination as a new biological-process companion annotation, because the core function includes TRAP1 ubiquitination.
  • Mark GO:0046982 protein heterodimerization activity as over-annotated: it is domain-consistent but less informative than the direct adaptor function.
  • Mark GO:0005515 protein binding as over-annotated: the YWHAE/14-3-3 interaction is a generic interaction record, not an informative molecular function.
  • Keep GO:0005654 nucleoplasm as non-core localization.

πŸ“š Additional Documentation

Notes

(ABTB2-notes.md)

ABTB2 notes

2026-06-03 Proteostasis PN review pass

  • Started from just fetch-gene human ABTB2, which seeded three GOA rows: InterPro-derived protein heterodimerization, IntAct/YWHAE protein binding, and HPA nucleoplasm localization.
  • Deep research attempt: just deep-research-falcon human ABTB2 --fallback perplexity-lite timed out for Falcon after 600 seconds; fallback to perplexity-lite failed with a Perplexity API quota error. Manual fallback evidence was written to ABTB2-deep-research-manual.md per project instructions.
  • PN context places ABTB2 under Ubiquitin Proteasome System > E3 ubiquitin and UBL ligases > Cul3 substrate receptor > BTB-BACK, variant > ankyrin and projects GO:1990756 ubiquitin-like ligase-substrate adaptor activity [file:projects/PROTEOSTASIS/reports/pn_projection/pn_projected_annotations.tsv "ABTB2 Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor|BTB-BACK, variant|ankyrin"].
  • Conservative nomenclature check: older BPOZ-2 papers are useful background for BTB/POZ substrate-adaptor biology, but I did not use them as primary ABTB2 evidence because BPOZ-2 nomenclature overlaps with ABTB1 and needs identifier-level confirmation before being projected to Q8N961. The cached TdT abstract says "BPOZ-2 bound to E3 ligase CUL3 in vitro and in vivo" PMID:18429817, but this was not the basis for the ABTB2 GO:1990756 decision.
  • Direct ABTB2 evidence comes from the 2025 PDAC paper. The abstract states that "ABTB2 interacts with tumour necrosis factor receptor-associated protein 1 (TRAP1), promoting its ubiquitin-dependent degradation" PMID:41322190. The results section confirms ABTB2-TRAP1 co-IP and TRAP1 ubiquitination PMID:41322190 PMID:41322190. The discussion adds "We also found that ABTB2 interacts with cullin-3 (Figure S9)" PMID:41322190.
  • Curation conclusion: accept the PN-projected GO:1990756 for ABTB2 as a new, direct, gene-specific molecular-function annotation, but do not overstate ABTB2 as a catalytic ubiquitin ligase. Mark existing generic binding/heterodimerization rows as over-annotated and keep nucleoplasm as non-core localization.

Pn Notes

(ABTB2-pn-notes.md)

ABTB2 PN Consistency Notes

  • Generated: 2026-06-18
  • Project: PROTEOSTASIS
  • Scope: PN consistency rereview against local AIGR review and available deep-research artifacts
  • UniProt: Q8N961
  • AIGR review status: COMPLETE
  • Review batch: proteostasis-batch-2026-06-03 (PR 1331)
  • Batch change status: added

Source Files Checked

Deep Research Files

AIGR Review Snapshot

  • Description: ABTB2 is a large ankyrin-repeat and BTB/POZ-domain protein with protein-protein interaction domains and isoform diversity. Direct experimental work in pancreatic ductal adenocarcinoma models supports a substrate-adaptor-like role in which ABTB2 binds TRAP1, promotes TRAP1 ubiquitination-dependent degradation, and suppresses Wnt/beta-catenin and PI3K/Akt signaling. ABTB2 has been detected in the nucleoplasm, but its normal tissue substrates and broader physiological roles remain incompletely defined.
  • Existing/core annotation action counts: KEEP_AS_NON_CORE: 1; MARK_AS_OVER_ANNOTATED: 2; NEW: 2

PN Consistency Summary

  • Consistency: Deep-research (manual fallback), notes, review YAML, and the PN Cul3-adaptor mapping are mutually consistent. All converge on ABTB2 as a BTB/POZ substrate-adaptor that binds CUL3 and promotes TRAP1 ubiquitin-dependent degradation (PMID:41322190). No contradictions. The review prudently treats older BPOZ-2 papers as nomenclature-ambiguous with ABTB1 and excludes them as primary evidence.
  • PN story / NEW pressure: PN asserts adaptor activity not in the original GOA (which had only GO:0046982 heterodimerization IEA, GO:0005515 protein binding IPI, GO:0005654 nucleoplasm). The review adds the PN-projected GO:1990756 (OLS-verified real) as a direct IDA NEW annotation, supported by ABTB2-TRAP1 co-IP, TRAP1 ubiquitination/degradation, and reported ABTB2-cullin-3 interaction, plus companion GO:0016567 protein ubiquitination. This is gene-specific support, not domain-only projection. Conclusion: legitimate ADD, executed in the review.
  • Evidence alignment: PN row references (PMID:15071497, 23912815 β€” generic Cul3/BTB reviews) do NOT overlap the review's primary evidence (PMID:41322190, the 2025 PDAC study); the review rests on stronger gene-specific data than the PN row's domain-review citations. Generic 14-3-3 interactome (PMID:36931259) shared but marked over-annotated.
  • Verdict: Fully consistent; PN GO:1990756 projection validated by direct evidence and correctly added as NEW. Recommended edits: none (mapping and review aligned).

Full Consistency Review

  • UniProt: Q8N961 Β· batch: proteostasis-batch-2026-06-03 Β· review status: COMPLETE
  • PN placement: Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor|BTB-BACK, variant|ankyrin ; PN-node mapping: group Cul3 substrate receptor=mappedβ†’GO:1990756 ubiquitin-like ligase-substrate adaptor activity (new_to_goa); class E3 ubiquitin and UBL ligases=context_only (too_broadβ†’GO:0061630); subtype/type/branch=no_mapping.
  • Consistency: Deep-research (manual fallback), notes, review YAML, and the PN Cul3-adaptor mapping are mutually consistent. All converge on ABTB2 as a BTB/POZ substrate-adaptor that binds CUL3 and promotes TRAP1 ubiquitin-dependent degradation (PMID:41322190). No contradictions. The review prudently treats older BPOZ-2 papers as nomenclature-ambiguous with ABTB1 and excludes them as primary evidence.
  • PN story / NEW pressure: PN asserts adaptor activity not in the original GOA (which had only GO:0046982 heterodimerization IEA, GO:0005515 protein binding IPI, GO:0005654 nucleoplasm). The review adds the PN-projected GO:1990756 (OLS-verified real) as a direct IDA NEW annotation, supported by ABTB2-TRAP1 co-IP, TRAP1 ubiquitination/degradation, and reported ABTB2-cullin-3 interaction, plus companion GO:0016567 protein ubiquitination. This is gene-specific support, not domain-only projection. Conclusion: legitimate ADD, executed in the review.
  • Mapping strategy: This gene strengthens the Cul3-substrate-receptor group mapping with direct experimental evidence (unlike its paralog ABTB3). The group-level GO:1990756 scope is appropriate (adaptor activity, not catalytic E3); the review correctly avoids GO:0061630 ubiquitin protein ligase activity. No change needed.
  • Evidence alignment: PN row references (PMID:15071497, 23912815 β€” generic Cul3/BTB reviews) do NOT overlap the review's primary evidence (PMID:41322190, the 2025 PDAC study); the review rests on stronger gene-specific data than the PN row's domain-review citations. Generic 14-3-3 interactome (PMID:36931259) shared but marked over-annotated.
  • Verdict: Fully consistent; PN GO:1990756 projection validated by direct evidence and correctly added as NEW. Recommended edits: none (mapping and review aligned).

PN Dossier Context

  • review_batch: proteostasis-batch-2026-06-03
  • review_yaml: genes/human/ABTB2/ABTB2-ai-review.yaml
  • PN workbook rows: 1

PN row 1: Ubiquitin Proteasome System | E3 ubiquitin and UBL ligases | Cul3 substrate receptor | BTB-BACK, variant | ankyrin

  • UniProt: Q8N961
  • In branches: UPS
  • Signature domains: IPR000210, cd18526
  • Auxiliary domains: IPR002110
  • PN references (titles):
    • 15071497 / rev
    • 23912815 / rev
  • PN-node mapping records (path + ancestors):
    • [subtype] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor|BTB-BACK, variant|ankyrin
      status=no_mapping scope= GO=[]
      rationale: Reviewed as a narrower substrate-receptor, adaptor, domain, or family subdivision already covered by the curated parent adaptor/receptor mapping. No additional direct GO mapping is needed at this node.
    • [type] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor|BTB-BACK, variant
      status=no_mapping scope= GO=[]
      rationale: Reviewed as a narrower substrate-receptor, adaptor, domain, or family subdivision already covered by the curated parent adaptor/receptor mapping. No additional direct GO mapping is needed at this node.
    • [group] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor
      status=mapped scope=ok_for_propagation_to_go GO=[GO:1990756 ubiquitin-like ligase-substrate adaptor activity]
      rationale: This PN group captures substrate receptors/adaptors for cullin/UBL ligase systems. The shared GO molecular-function target is ubiquitin-like ligase-substrate adaptor activity.
    • [class] Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases
      status=context_only scope=too_broad_to_propagate GO=[GO:0061630 ubiquitin protein ligase activity]
      rationale: This class is a genuine E3-ligase context, but its descendants include catalytic ligases, cullin scaffolds, substrate receptors, adaptors, cofactors, regulators, and UBL modifier systems. A class-level propagation would over-annotate.
    • [branch] Ubiquitin Proteasome System
      status=no_mapping scope= GO=[]
      rationale: Reviewed as the top-level UPS branch. It is a project taxonomy umbrella rather than a direct GO assertion; UPS propagation must come from manually curated child nodes.

Projected GO annotations (1)

  • GO:1990756 ubiquitin-like ligase-substrate adaptor activity | scope=ok_for_propagation_to_go | goa_status=new_to_goa | from=Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor

Note

This file is generated from the current PROTEOSTASIS phase-1 dossier and local gene-review artifacts. Edit the source review, PN mapping, or dossier rather than this generated note when correcting the underlying curation.

πŸ“„ View Raw YAML

id: Q8N961
gene_symbol: ABTB2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  ABTB2 is a large ankyrin-repeat and BTB/POZ-domain protein with protein-protein
  interaction domains and isoform diversity. Direct experimental work in pancreatic
  ductal adenocarcinoma models supports a substrate-adaptor-like role in which
  ABTB2 binds TRAP1, promotes TRAP1 ubiquitination-dependent degradation, and
  suppresses Wnt/beta-catenin and PI3K/Akt signaling. ABTB2 has been detected in
  the nucleoplasm, but its normal tissue substrates and broader physiological
  roles remain incompletely defined.
alternative_products:
- name: '1'
  id: Q8N961-1
- name: '2'
  id: Q8N961-2
  sequence_note: VSP_046439
existing_annotations:
- term:
    id: GO:0046982
    label: protein heterodimerization activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      This InterPro-derived annotation is consistent with ABTB2 containing
      protein-interaction domains, including histone-fold-like, ankyrin-repeat,
      and BTB/POZ features, but it is too broad to describe ABTB2's best-supported
      molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Retain the domain context but do not treat generic heterodimerization as a
      core function. The direct ABTB2 literature supports a more informative
      substrate-adaptor-like role in TRAP1 ubiquitination-dependent degradation,
      captured below as GO:1990756.
    additional_reference_ids:
    - PMID:41322190
    - file:human/ABTB2/ABTB2-deep-research-manual.md
    supported_by:
    - reference_id: UniProt:Q8N961
      supporting_text: 'DR   InterPro; IPR009072; Histone-fold.'
    - reference_id: PMID:41322190
      supporting_text: >-
        ABTB2 interacts with tumour necrosis factor receptor-associated protein 1
        (TRAP1), promoting its ubiquitin-dependent degradation
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:36931259
  qualifier: enables
  review:
    summary: >-
      The IPI annotation records a 14-3-3 epsilon/YWHAE interaction detected in
      a broad 14-3-3 interactome study. This supports an ABTB2 protein interaction
      but not a specific molecular activity.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      GO:0005515 is intentionally generic and is not useful as a retained core
      molecular-function annotation. ABTB2's direct, more informative function is
      better represented as ubiquitin-like ligase-substrate adaptor activity.
    additional_reference_ids:
    - PMID:41322190
    - file:human/ABTB2/ABTB2-deep-research-manual.md
    supported_by:
    - reference_id: UniProt:Q8N961
      supporting_text: 'CC       Q8N961; P62258: YWHAE; NbExp=2; IntAct=EBI-11603395, EBI-356498;'
    - reference_id: PMID:36931259
      supporting_text: >-
        Here, we map the interactomes of all human 14-3-3 paralogs
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      HPA immunofluorescence supports nucleoplasm localization. Direct ABTB2
      functional work also links the protein to intracellular protein-complex
      contexts, but localization is not itself the core proteostasis function.
    action: KEEP_AS_NON_CORE
    reason: >-
      Keep as a supported localization/context annotation. It should not be used
      to infer a nuclear-specific core function, since the strongest mechanistic
      evidence concerns ABTB2-dependent TRAP1 ubiquitination and degradation in
      cancer models.
    additional_reference_ids:
    - PMID:41322190
    - file:human/ABTB2/ABTB2-deep-research-manual.md
- term:
    id: GO:1990756
    label: ubiquitin-like ligase-substrate adaptor activity
  evidence_type: IDA
  original_reference_id: PMID:41322190
  qualifier: enables
  review:
    summary: >-
      Lyu et al. identify TRAP1 as an ABTB2-interacting protein and show that
      ABTB2 overexpression increases TRAP1 ubiquitination and promotes TRAP1
      degradation. The same study reports ABTB2 interaction with cullin-3, making
      the PN-projected Cul3 substrate-receptor context supportable for ABTB2.
    action: NEW
    reason: >-
      This is the most informative molecular-function term for the direct ABTB2
      evidence. It captures ABTB2's substrate-adaptor-like role in bringing a
      ubiquitin-ligase system to a substrate, while avoiding a catalytic E3-ligase
      annotation. The older BPOZ-2/TdT and BPOZ-2/eEF1A1 literature was not used
      as primary ABTB2 evidence because that nomenclature overlaps with ABTB1;
      the 2025 ABTB2/TRAP1 study provides direct gene-specific support.
    additional_reference_ids:
    - file:projects/PROTEOSTASIS/reports/pn_projection/pn_projected_annotations.tsv
    - file:human/ABTB2/ABTB2-deep-research-manual.md
    supported_by:
    - reference_id: PMID:41322190
      supporting_text: >-
        Co-immunoprecipitation using Abs specific to ABTB2 and TRAP1, followed
        by western blotting, confirmed the specific interaction between ABTB2 and
        TRAP1
    - reference_id: PMID:41322190
      supporting_text: >-
        multiple mono-ubiquitinated TRAP1 (Figures 8F and S10) in ABTB2-OE cells,
        suggesting that ABTB2-induced protein ubiquitination contributes to TRAP1
        degradation
    - reference_id: PMID:41322190
      supporting_text: >-
        We also found that ABTB2 interacts with cullin-3 (Figure S9)
    - reference_id: file:human/ABTB2/ABTB2-deep-research-manual.md
      supporting_text: >-
        Direct ABTB2 evidence supports a substrate-adaptor-like role for TRAP1
        ubiquitination-dependent degradation.
- term:
    id: GO:0016567
    label: protein ubiquitination
  evidence_type: IDA
  original_reference_id: PMID:41322190
  qualifier: involved_in
  review:
    summary: >-
      ABTB2 overexpression increases pan-protein ubiquitination and TRAP1
      ubiquitination, with TRAP1 degradation downstream of the ABTB2-TRAP1
      interaction.
    action: NEW
    reason: >-
      Add as a biological-process companion to the molecular-function adaptor
      annotation. The evidence supports ABTB2 involvement in TRAP1 protein
      ubiquitination, while the molecular-function annotation should remain
      adaptor activity rather than catalytic ubiquitin ligase activity.
    additional_reference_ids:
    - file:human/ABTB2/ABTB2-deep-research-manual.md
    supported_by:
    - reference_id: PMID:41322190
      supporting_text: >-
        Using western blotting, we detected abundant ubiquitination of whole
        proteins (Figure 8E) and multiple mono-ubiquitinated TRAP1 (Figures 8F
        and S10) in ABTB2-OE cells
    - reference_id: PMID:41322190
      supporting_text: >-
        ABTB2 promotes TRAP1 degradation via ubiquitination (Figure 8)
    - reference_id: file:human/ABTB2/ABTB2-deep-research-manual.md
      supporting_text: >-
        Add `GO:0016567 protein ubiquitination` as a new biological-process
        companion annotation
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings:
  - statement: >-
      InterPro-based annotation projected a generic protein heterodimerization
      activity term to ABTB2 from domain associations.
    supporting_text: >-
      The ABTB2 GOA record includes an IEA annotation to GO:0046982 protein
      heterodimerization activity with GO_REF:0000002 as the source reference.
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings:
  - statement: >-
      Immunofluorescence-based curation supports nucleoplasm localization for
      ABTB2.
    supporting_text: >-
      The ABTB2 GOA record includes an IDA annotation to GO:0005654 nucleoplasm
      with GO_REF:0000052 as the source reference.
- id: PMID:36931259
  title: A central chaperone-like role for 14-3-3 proteins in human cells.
  findings:
  - statement: >-
      ABTB2 was identified as an interactor of 14-3-3 epsilon (YWHAE) in a
      systematic mapping of human 14-3-3 paralog interactomes.
    supporting_text: >-
      Here, we map the interactomes of all human 14-3-3 paralogs
- id: PMID:41322190
  title: Mechanistic and functional characterization of ABTB2 as a novel target for
    pancreatic cancer therapy.
  findings:
  - statement: >-
      ABTB2 interacts with TRAP1 and promotes TRAP1 ubiquitination-dependent
      degradation in pancreatic cancer models.
    supporting_text: >-
      Transcriptomic analysis, immunoprecipitation, and functional assays
      demonstrated that ABTB2 interacts with tumour necrosis factor
      receptor-associated protein 1 (TRAP1), promoting its ubiquitin-dependent
      degradation
  - statement: >-
      The authors report that ABTB2 also interacts with cullin-3, supporting
      a substrate-adaptor-like model.
    supporting_text: >-
      We also found that ABTB2 interacts with cullin-3 (Figure S9)
- id: UniProt:Q8N961
  title: UniProt record for ABTB2 (Q8N961)
  findings:
  - statement: ABTB2 contains ankyrin-repeat and BTB/POZ-domain features.
    supporting_text: >-
      FT                   /note="BTB"
- id: file:projects/PROTEOSTASIS/reports/pn_projection/pn_projected_annotations.tsv
  title: Proteostasis PN projected annotation report
  findings:
  - statement: >-
      The Proteostasis PN projection places ABTB2 in the Cul3 substrate-receptor
      branch and projects GO:1990756.
    supporting_text: >-
      ABTB2		Ubiquitin Proteasome System|E3 ubiquitin and UBL ligases|Cul3 substrate receptor|BTB-BACK, variant|ankyrin
- id: file:human/ABTB2/ABTB2-deep-research-manual.md
  title: Manual deep research fallback for ABTB2 PN review
  findings:
  - statement: >-
      Manual fallback review supports accepting GO:1990756 for ABTB2 based on
      direct ABTB2-TRAP1 ubiquitination/degradation and reported ABTB2-cullin-3
      interaction.
    supporting_text: >-
      Direct ABTB2 evidence supports a substrate-adaptor-like role for TRAP1
      ubiquitination-dependent degradation.
core_functions:
- description: >-
    ABTB2 acts as a BTB/POZ substrate-adaptor-like protein for ubiquitin-dependent
    degradation of TRAP1 in pancreatic cancer models, consistent with the
    Proteostasis PN Cul3 substrate-receptor projection.
  molecular_function:
    id: GO:1990756
    label: ubiquitin-like ligase-substrate adaptor activity
  directly_involved_in:
  - id: GO:0016567
    label: protein ubiquitination
  substrates:
  - id: UniProtKB:Q12931
    label: TRAP1
  supported_by:
  - reference_id: PMID:41322190
    supporting_text: >-
      ABTB2 promotes TRAP1 degradation via ubiquitination (Figure 8). We also
      found that ABTB2 interacts with cullin-3 (Figure S9)
suggested_questions:
- question: >-
    Does endogenous ABTB2 form a native CRL3 complex with CUL3 in non-cancer
    tissues, and is TRAP1 a physiological substrate outside pancreatic cancer
    models?
- question: >-
    What additional ABTB2 substrates explain its tissue-specific and disease-context
    effects?
suggested_experiments:
- description: >-
    Test endogenous ABTB2-CUL3-TRAP1 complex formation with reciprocal co-IP,
    proximity ligation, and BTB-domain mutant rescue in cells with native ABTB2
    expression.
  hypothesis: >-
    ABTB2 uses its BTB/POZ domain to recruit CUL3 while its substrate-recognition
    regions engage TRAP1.
  experiment_type: co-immunoprecipitation and mutant rescue
- description: >-
    Measure TRAP1 ubiquitination and stability after ABTB2 loss or rescue with
    CUL3 depletion, proteasome inhibition, and ubiquitin-linkage/site mapping.
  hypothesis: >-
    ABTB2-dependent TRAP1 degradation requires a CUL3 ubiquitin-ligase complex.
  experiment_type: ubiquitination and protein-turnover assay